Description: This paper develops a formal framework to model the behavior of individual and small group health insurance policies in a competitive market. In this framework, anti-selective lapse is not assumed, but arises as a result of rational consumers seeking the best value in a competitive market where the premium rates are restricted by law. The authors obtain a model that addresses a number of fundamental questions which have not been fully answered previously, including the effect of price-induced anti-selective lapse on the mix of insureds in a block and the optimal renewal price to maximize the aggregate profit of a block.

Description: This paper is about an Interacting Particle System [IPS] approach to modeling treatment costs associated with a multiple stage pandemic. The model population receives differing treatments with possibly differing costs depending on the stage of exposure/infection. The total cost of treatment is a time varying utility function of the ensemble population for which this approach uses particle system methods to simulate the cost of maintaining survival of the population. The paper gives a brief background on particle systems with specific focus on 'the contact process', followed by expanding the contact process to represent more realistic state transitions.

Description: The Actuary Vol. 22, No. 6. The author provides commentary regarding an interview with Paul Barnhart reported on in The Actuary March 1988 concerning the controversy over health insurance reserves. Specifically the elements of the “Benefit Ratio Reserve” method were analyzed.

Description: This paper describes a computer package for analyzing AIDS data named AIDS-PAC that: 1. adjusts AIDS case counts to account for reporting delay, 2. estimates the size of the HIV infected population, 3. provides short-term forecasts of the extent of the AIDS epidemic. Actuarial Research Clearing House 1991 VOL. 1

Description: Report to give actuaries practical information and guidance on LTD claim credibility for case level pricing and underwriting. Stage 2 of the GLTD Credibility Study, this analysis was expanded using the industry data gathered during Stage 1.

Description: How do we take a Minimum Viable Products (MVP) approach to launch new insurance products? Join this moderated discussion and focus on three key development aspects: Distribution, Systems, and the design and pricing of the Insurance product itself. Come discuss reasons to choose an MVP approach and how it solves many of the product launch challenges.

Description: These discussions at the 1967 New York and New Orleans Regional Meetings covered topics related to individual life and health insurance including health topics, individual life underwriting, reinsurance, individual policy pension fund expenses, tax sheltered annuities, and market testing products.

Description: Discussion of the standards set by ASOP 23 on data quality within a health insurance context.

Description: This general discussion looks at mortality experience with the advent of CSO tables, annuity premium tax, termination dividends, classes of agents included under Social Security, and conditions affecting companies entering the fields of disability income, accident, health, hospitalization and medical insurance.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.